The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4S)-4-[[(2S)-2-acetamido-3-carboxy-propanoyl]amino]-5-[[(1S)-1-[[(1S)-1-(carboxymethyl)-2,3-dioxo-propyl]carbamoyl]-2-methyl-propyl]amino]-5-oxo-pentanoic acid ID: ALA4782926
PubChem CID: 101009379
Max Phase: Preclinical
Molecular Formula: C21H30N4O12
Molecular Weight: 530.49
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)C=O)C(C)C
Standard InChI: InChI=1S/C21H30N4O12/c1-9(2)18(21(37)24-12(6-16(31)32)14(28)8-26)25-19(35)11(4-5-15(29)30)23-20(36)13(7-17(33)34)22-10(3)27/h8-9,11-13,18H,4-7H2,1-3H3,(H,22,27)(H,23,36)(H,24,37)(H,25,35)(H,29,30)(H,31,32)(H,33,34)/t11-,12-,13-,18-/m0/s1
Standard InChI Key: LUOWSNAZOQEWCS-RSLFNQERSA-N
Molfile:
RDKit 2D
37 36 0 0 0 0 0 0 0 0999 V2000
7.0270 -11.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7398 -11.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7398 -10.3783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4530 -11.6184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1661 -11.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8834 -11.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5966 -11.2036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3097 -11.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0228 -11.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7401 -11.6184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4533 -11.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1664 -11.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8796 -11.2036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5968 -11.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3100 -11.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0231 -11.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7404 -11.2036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3100 -10.3783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5968 -12.4436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3100 -12.8543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3100 -13.6796 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0231 -12.4436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1664 -12.4436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4533 -10.3783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7401 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1664 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0228 -10.3783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3097 -12.4436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0228 -12.8543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0228 -13.6796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7401 -14.0901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3097 -14.0901 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8834 -12.4436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1661 -10.3783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8834 -9.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8834 -9.1424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6810 -10.1814 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
15 18 2 0
14 19 1 6
19 20 1 0
20 21 1 0
20 22 2 0
12 23 2 0
11 24 1 1
24 25 1 0
24 26 1 0
9 27 2 0
8 28 1 6
28 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
6 33 2 0
5 34 1 1
34 35 1 0
35 36 2 0
35 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 530.49Molecular Weight (Monoisotopic): 530.1860AlogP: -2.82#Rotatable Bonds: 17Polar Surface Area: 262.44Molecular Species: ACIDHBA: 9HBD: 7#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.44CX Basic pKa: ┄CX LogP: -2.70CX LogD: -12.23Aromatic Rings: ┄Heavy Atoms: 37QED Weighted: 0.07Np Likeness Score: 0.37
References 1. Bancet A,Raingeval C,Lomberget T,Le Borgne M,Guichou JF,Krimm I. (2020) Fragment Linking Strategies for Structure-Based Drug Design., 63 (20.0): [PMID:32539387 ] [10.1021/acs.jmedchem.0c00242 ]